Skip to main content
. 2020 Sep 4;10:1697. doi: 10.3389/fonc.2020.01697

Figure 1.

Figure 1

Participant screening flow chart. We screened 136 participants, including 43 healthy women, 44 benign and 49 EC patients. Among 44 benign patients, 3 patients with other tumors were excluded. Among 49 EC patients, 6 EC patients lacked pre-operative blood samples, and 1 patients with metastatic EC were excluded. Among 42 patients included in the EC group, paired pre- and post-operative blood samples were obtained from 12 patients.